Income Tax Expense (Benefit) in USD of UNITED THERAPEUTICS Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q3 2025.
  • UNITED THERAPEUTICS Corp Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $99.3M, a 24.9% increase year-over-year.
  • UNITED THERAPEUTICS Corp Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $395M, a 20.7% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2024 was $344M, a 18.8% increase from 2023.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2023 was $290M, a 29.6% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2022 was $223M, a 89.1% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

UNITED THERAPEUTICS Corp Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $395M $99.3M +$19.8M +24.9% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $375M $98.9M +$21.7M +28.1% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 $353M $101M +$9.3M +10.1% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $344M $95.2M +$16.9M +21.6% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2025
Q3 2024 $327M $79.5M -$4.7M -5.58% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $332M $77.2M +$1.2M +1.58% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $331M $92M +$41M +80.4% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $290M $78.3M +$31.6M +67.7% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2025
Q3 2023 $258M $84.2M +$11M +15% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 $247M $76M +$41.4M +120% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024
Q1 2023 $206M $51M -$17.8M -25.9% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024
Q4 2022 $223M $46.7M +$18.4M +65% 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2025
Q3 2022 $205M $73.2M +$31.5M +75.5% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $173M $34.6M -$9.3M -21.2% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023
Q1 2022 $183M $68.8M +$64.6M +1538% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $118M $28.3M +$12.7M +81.4% 01 Oct 2021 31 Dec 2021 10-K 21 Feb 2024
Q3 2021 $105M $41.7M -$6.1M -12.8% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $112M $43.9M +$17.1M +63.8% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $94.4M $4.2M -$29.7M -87.6% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 $124M $15.6M -$100K -0.64% 01 Oct 2020 31 Dec 2020 10-K 22 Feb 2023
Q3 2020 $124M $47.8M +$13.3M +38.6% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $111M $26.8M -$18.5M -40.8% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $129M $33.9M +$190M 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$60.5M $15.7M -$10.9M -41% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022
Q3 2019 -$49.6M $34.5M +$900K +2.68% 01 Jul 2019 30 Sep 2019 10-Q 28 Oct 2020
Q2 2019 -$50.5M $45.3M +$300K +0.67% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 -$50.8M -$156M -$221M -342% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $170M $26.6M -$95.4M -78.2% 01 Oct 2018 31 Dec 2018 10-K 24 Feb 2021
Q3 2018 $265M $33.6M -$10.8M -24.3% 01 Jul 2018 30 Sep 2018 10-Q 30 Oct 2019
Q2 2018 $276M $45M -$55.2M -55.1% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 $331M $64.5M -$20.5M -24.1% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019
Q4 2017 $352M $122M +$60.8M +99.3% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 $291M $44.4M -$32.9M -42.6% 01 Jul 2017 30 Sep 2017 10-Q 31 Oct 2018
Q2 2017 $324M $100M +$20.6M +25.9% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $303M $85M -$43.4M -33.8% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $347M $61.2M +$9.8M +19.1% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019
Q3 2016 $337M $77.3M -$195M -71.6% 01 Jul 2016 30 Sep 2016 10-Q 25 Oct 2017
Q2 2016 $532M $79.6M +$10.4M +15% 01 Apr 2016 30 Jun 2016 10-Q 27 Jul 2017
Q1 2016 $521M $128M +$129M 01 Jan 2016 31 Mar 2016 10-Q 26 Apr 2017
Q4 2015 $393M $51.4M -$7.42M -12.6% 01 Oct 2015 31 Dec 2015 10-K 21 Feb 2018
Q3 2015 $400M $272M +$283M 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 $117M $69.2M +$8.02M +13.1% 01 Apr 2015 30 Jun 2015 10-Q 28 Jul 2016
Q1 2015 $109M -$200K -$75.9M -100% 01 Jan 2015 31 Mar 2015 10-Q 28 Apr 2016
Q4 2014 $185M $58.8M +$60.1M 01 Oct 2014 31 Dec 2014 10-K 22 Feb 2017
Q3 2014 $125M -$10.6M -$49.1M -128% 01 Jul 2014 30 Sep 2014 10-Q 27 Oct 2015
Q2 2014 $174M $61.2M +$22.5M +58.3% 01 Apr 2014 30 Jun 2014 10-Q 28 Jul 2015
Q1 2014 $152M $75.7M +$47.2M +165% 01 Jan 2014 31 Mar 2014 10-Q 28 Apr 2015
Q4 2013 $104M -$1.32M -$43M -103% 01 Oct 2013 31 Dec 2013 10-K 25 Feb 2016
Q3 2013 $147M $38.5M +$8.11M +26.7% 01 Jul 2013 30 Sep 2013 10-Q 28 Oct 2014
Q2 2013 $139M $38.7M +$7.68M +24.8% 01 Apr 2013 30 Jun 2013 10-Q 29 Jul 2014
Q1 2013 $132M $28.5M -$4.67M -14.1% 01 Jan 2013 31 Mar 2013 10-Q 29 Apr 2014
Q4 2012 $136M $41.7M +$25.6M +160% 01 Oct 2012 31 Dec 2012 10-K 24 Feb 2015
Q3 2012 $111M $30.4M +$12.7M +72.2% 01 Jul 2012 30 Sep 2012 10-Q 29 Oct 2013
Q2 2012 $97.9M $31M -$4.75M -13.3% 01 Apr 2012 30 Jun 2012 10-Q 25 Jul 2013
Q1 2012 $103M $33.2M +$20.7M +167% 01 Jan 2012 31 Mar 2012 10-Q 25 Apr 2013
Q4 2011 $81.9M $16.1M +$19.4M 01 Oct 2011 31 Dec 2011 10-K 25 Feb 2014
Q3 2011 $62.4M $17.6M -$576K -3.16% 01 Jul 2011 30 Sep 2011 10-Q 01 Nov 2012
Q2 2011 $63M $35.7M +$16.4M +84.7% 01 Apr 2011 30 Jun 2011 10-Q 26 Jul 2012
Q1 2011 $46.6M $12.4M +$2.69M +27.6% 01 Jan 2011 31 Mar 2011 10-Q 26 Apr 2012
Q4 2010 $43.9M -$3.37M 01 Oct 2010 31 Dec 2010 10-K 26 Feb 2013
Q3 2010 $18.2M 01 Jul 2010 30 Sep 2010 10-Q 27 Oct 2011
Q2 2010 $19.3M 01 Apr 2010 30 Jun 2010 10-Q 28 Jul 2011
Q1 2010 $9.75M 01 Jan 2010 31 Mar 2010 10-Q 28 Apr 2011

UNITED THERAPEUTICS Corp Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $344M +$54.4M +18.8% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025
2023 $290M +$66.2M +29.6% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025
2022 $223M +$105M +89.1% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025
2021 $118M -$6M -4.84% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2024
2020 $124M +$185M 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023
2019 -$60.5M -$230M -136% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 $170M -$182M -51.7% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 $352M +$5.1M +1.47% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 $347M -$46.3M -11.8% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 $393M +$208M +112% 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018
2014 $185M +$80.8M +77.4% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017
2013 $104M -$31.9M -23.4% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016
2012 $136M +$54.4M +66.4% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015
2011 $81.9M +$37.9M +86.3% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014
2010 $43.9M 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.